Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study

BACKGROUND: S-1 adjuvant chemotherapy is the standard treatment in Asia for resectable pancreatic ductal adenocarcinoma. The relative dose intensity of adjuvant chemotherapy influences survival in pancreatic cancer but does not precisely reflect treatment schedule modifications. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuki, Einama, Takahiro, Takihata, Yasuhiro, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Kouzu, Keita, Nakazawa, Akiko, Iwasaki, Toshimitsu, Ueno, Hideki, Kishi, Yoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524130/
https://www.ncbi.nlm.nih.gov/pubmed/36180830
http://dx.doi.org/10.1186/s12885-022-10116-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524130/
https://www.ncbi.nlm.nih.gov/pubmed/36180830
http://dx.doi.org/10.1186/s12885-022-10116-2

Ejemplares similares